Literature DB >> 15747373

Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery.

Walter Kolch1, Christian Neusüss, Matthias Pelzing, Harald Mischak.   

Abstract

Proteome analysis is now emerging as key technology for deciphering biological processes and the discovery of biomarkers for diseases from tissues and body fluids. The complexity and wide dynamic range of protein expression poses a formidable challenge to both peptide separation technologies and mass spectrometry (MS). Here we review the efforts that have been undertaken to date, focussing on capillary electrophoresis coupled to mass spectrometry (CE-MS). We discuss CE-MS from an application point of view evaluating its merits and vices in regard to biomarker discovery and clinical applications. As examples, we present the use of CE-MS for the determination of protein patterns in urine, serum, and other body fluids. Finally, the benefits and limitations of CE-MS for the analysis of proteins in clinical samples are discussed against the background of alternative technologies. (c) 2005 Wiley Periodicals, Inc., Mass Spec Rev 24:959-977, 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15747373     DOI: 10.1002/mas.20051

Source DB:  PubMed          Journal:  Mass Spectrom Rev        ISSN: 0277-7037            Impact factor:   10.946


  59 in total

Review 1.  The application of mass-spectrometry-based protein biomarker discovery to theragnostics.

Authors:  Jonathan M Street; James W Dear
Journal:  Br J Clin Pharmacol       Date:  2010-04       Impact factor: 4.335

2.  A method for isolation and identification of urinary biomarkers in patients with diabetic nephropathy.

Authors:  Wayne G Fisher; Jessica E Lucas; Uzma F Mehdi; Danna W Qunibi; Harold R Garner; Kevin P Rosenblatt; Robert D Toto
Journal:  Proteomics Clin Appl       Date:  2011-12       Impact factor: 3.494

Review 3.  [Proteome-based diagnostic and prognostic biomarkers of prostate cancer].

Authors:  J Neuhaus; E Schiffer; J Siwy; F Mannello; L-C Horn; J-U Stolzenburg
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

Review 4.  Mass spectrometry based proteomics in urine biomarker discovery.

Authors:  Dan Theodorescu; Harald Mischak
Journal:  World J Urol       Date:  2007-08-17       Impact factor: 4.226

5.  Microarray methods for protein biomarker detection.

Authors:  Hye Jin Lee; Alastair W Wark; Robert M Corn
Journal:  Analyst       Date:  2008-06-05       Impact factor: 4.616

Review 6.  Mass spectrometry in chronic kidney disease research.

Authors:  Michael L Merchant
Journal:  Adv Chronic Kidney Dis       Date:  2010-11       Impact factor: 3.620

Review 7.  Proteomic biomarkers in kidney disease: issues in development and implementation.

Authors:  Harald Mischak; Christian Delles; Antonia Vlahou; Raymond Vanholder
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

8.  High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine.

Authors:  Harald Mischak; Bruce A Julian; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2007-07-10       Impact factor: 3.494

Review 9.  Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?

Authors:  Massimo Papale; Salvatore Di Paolo; Grazia Vocino; Maria Teresa Rocchetti; Loreto Gesualdo
Journal:  J Nephrol       Date:  2014-02-25       Impact factor: 3.902

Review 10.  Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.

Authors:  Cécile Caubet; Chrystelle Lacroix; Stéphane Decramer; Jens Drube; Jochen H H Ehrich; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.